Skip to main content

Biotech stocks are doing something that could result in a double-digit rally, trader says

The last five times the iShares' Biotechnology ETF (IBB) got this oversold, it subsequently rallied between 18% and 40%, says Miller Tabak's Matt Maley.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.